Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive Disorders

Summary

The clinical trial to valuate efficacy and safety of MMH-MAP in the treatment of cognitive disorders in patients with ischemic stroke in the carotid arteries.

Timeline

Start

2019-12-12

Primary completion

2023-02-07

Completion

2023-02-07

Outcome

Met primary endpoint

registry analysis (superiority test); MMH-MAP vs Placebo; p = 0.0006; Mean Difference (Final Values) 1.09 (95% CI 0.47 to 1.70); t-test, 2 sided NCT04295681 ↗

Drugs

Indications